|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||84.58 - 85.42|
|52 Week Range||52.25 - 85.54|
|PE Ratio (TTM)||48.34|
|Earnings Date||May 2, 2018 - May 7, 2018|
|Forward Dividend & Yield||0.50 (0.60%)|
|1y Target Est||84.35|
NEW YORK, March 07, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of ...
Zoetis Inc. will participate in the Cowen and Company 38th Annual Health Care Conference on Wednesday, March 14, 2018, in Boston, Mass. Clint Lewis, Executive Vice President and President, International Operations, will represent the company and respond to questions from analysts.
Stocks that moved substantially or traded heavily Thursday: Cisco Systems Inc., up $1.99 to $44.08 The technology company had a solid second quarter and said it will buy back $25 billion in stock. Teva ...
Zoetis' (ZTS) results exceed both earnings and sales expectations in the fourth quarter of 2017, making it the first animal health company to deliver more than $5 billion in revenues.
On a per-share basis, the Parsippany, New Jersey-based company said it had net income of 16 cents. Earnings, adjusted for non-recurring costs and costs related to mergers and acquisitions, were 69 cents ...
Zoetis Inc. today reported its financial results for the fourth quarter and full year 2017 and provided full year guidance for 2018.
Inflation pressures appear to be building in the economy and Thursday will give investors a look at how this is impacting producers after learning consumer prices are on the rise.
The Board of Directors of Zoetis Inc. has declared a second quarter 2018 dividend payable to holders of the company’s common stock of $0.126 per share. The dividend is to be paid on Friday, June 1, 2018, to holders of record on Friday, April 20, 2018.
Zoetis Inc. will participate in the Bank of America Merrill Lynch Animal Health Summit on Monday, Feb. 26, 2018, in New York, NY. Glenn David, Chief Financial Officer, will represent the company and respond to questions from analysts.
Short interest is extremely low for ZTS with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting ZTS. The net inflows of $6.41 billion over the last one-month into ETFs that hold ZTS are among the lowest of the last year and appear to be slowing.
Short interest is extremely low for ZTS with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting ZTS. Over the last month, growth of ETFs holding ZTS is favorable, with net inflows of $14.67 billion.
Zacks.com featured highlights include: Tempur Sealy, MSCI, Zoetis, Darden Restaurants and Illinois Tool Works
If you’re looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy. Unlike a blend strategy, a portfolio that uses GARP investing is expected to include stocks that offer the best of both value and growth investing. The GARP approach helps to zero in on stocks that are priced below the market or any reasonable target determined by fundamental analysis.
If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.
The Zacks Analyst Blog Highlights: Johnson & Johnson, AbbVie, Amgen, Novo-Nordisk and Zoetis